White House announces new push to increase supply of CV-19 treatment pills

The White House on Tuesday announced new measures to make the most effective CVD-19 treatment pills available from Pfizer, and said more lives could be saved if the pills were increased.

Pfizer pills, known as paxlovides, have been approved since December and have been taken as a key step in moving the virus to a new epidemic. But the administration acknowledged reports that some patients were having difficulty accessing them, and that awareness could be improved between the public and doctors.

To increase access, the administration announced on Tuesday morning that the location of the pills would soon increase from 20,000 to 30,000 and that it would work with pharmacies to increase the number to 40,000 “in the coming weeks.”

Authorities are exploring federally-funded “treatment” sites, where patients are tested for covad-19, and if positive they have the opportunity to order the pills immediately. The new stations will expand to the current 2,200.

Eligibility is “for people at high risk of transitioning to high CV-19” but according to a senior administration official, it could be agreed with many people who have tested positive for up to 60 percent, including those with diabetes or obesity. .

The administration is strengthening its training for doctors, including Monday’s Centers for Disease Control and Prevention, to encourage qualified people to be appointed.

“Paxlovid was initially in short supply after being approved by the Food and Drug Administration (FDA), but the administration is working with Pfizer to expedite the supply of these pills,” the White House said in a statement.

A senior administration official added that doctors have come out of the “shortage of ideas” around the drug and that many people are now able to get it compared to the limited supply in the early days.

Increasing access to the drugs is seen as a key to eliminating the virus and ensuring that no malicious actions, such as mask commands, are needed. Paxlovid has been shown to reduce the risk of hospitalization or death by 90%, but treatment should begin within five days of the onset of symptoms.

Asked how many people are using the pills, why not provide a list of vaccines, a senior administration official said in a statement on Monday.

About 500,000 antiretroviral treatment courses have been offered so far, the official said, adding that the use has increased from about 22,000 courses a week to about 55,000 a week.

Leave a Comment